Sunshine Biopharma (SBFM) Current Leases (2019 - 2026)
Sunshine Biopharma's (SBFM) quarterly Current Leases came in at $209226.0 in Q1 2026, down 2.22% YoY from $213983.0 in Q1 2025, and down 2.97% on a QoQ basis from $215637.0 in Q4 2025.
Sunshine Biopharma (SBFM) Current Leases (2019 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 6 years of Current Leases data on file, last reported at $209226.0 in Q1 2026.
- Quarterly Current Leases fell 2.22% year-over-year to $209226.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $209226.0 (down 2.22% YoY) and the FY2025 annual result came in at $215637.0, up 3.79% from the prior year.
- Current Leases eased to $209226.0 in Q1 2026, from $215637.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $222496.0 in Q2 2025 to a low of $114452.0 in Q2 2024.
- A 5-year average of $159731.4 and a median of $122586.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases dropped 6.3% — and 2025, when it jumped 94.4%.
- Tracing SBFM's Current Leases over 5 years: stood at $123026.0 in 2022, then decreased by 3.54% to $118670.0 in 2023, then jumped by 75.07% to $207756.0 in 2024, then grew by 3.79% to $215637.0 in 2025, then slipped by 2.97% to $209226.0 in 2026.
- The last three Current Leases figures came in at $209226.0 (Q1 2026), $215637.0 (Q4 2025), and $218053.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 202,518.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 202,518.00 |
| Mar 31, 2026 | 209,226.00 |
| Dec 31, 2025 | 215,637.00 |
| Sep 30, 2025 | 218,053.00 |
| Jun 30, 2025 | 222,496.00 |
| Mar 31, 2025 | 213,983.00 |
| Dec 31, 2024 | 207,756.00 |
| Sep 30, 2024 | 116,253.00 |
| Jun 30, 2024 | 114,452.00 |
| Mar 31, 2024 | 115,398.00 |
| Dec 31, 2023 | 118,670.00 |
| Sep 30, 2023 | 117,840.00 |
| Jun 30, 2023 | 122,146.00 |
| Mar 31, 2023 | 121,303.00 |
| Dec 31, 2022 | 123,026.00 |
| Mar 31, 2019 | 46,461.00 |